Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase I
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Phase I
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Phase I
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Phase I
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Phase I
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Phase I
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Phase I
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Phase I
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Phase I
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Phase I
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
Phase I
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus – FirstWord Pharma
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord Pharma
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
0
Phase I
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)...
Firstwordpharma News
-
July 18, 2020
0
1
2
3
...
89
Page 1 of 89
- Advertisement -
MOST POPULAR
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for...
February 4, 2020
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with...
March 8, 2019
New Pharma Invention Index Picks AstraZeneca as Top Company
November 5, 2019
Opiant Pharmaceuticals Announces Development Collaboration with National Center for Advancing Translational...
January 2, 2020
Load more
HOT NEWS
Approval
Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study
Deals
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for...
Commercial
F-star Presents New Data on its Tetravalent Bispecific Antibodies at the...
Commercial
Scottish Medicines Consortium epoetin alfa (Eprex)
